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Evaluation of Timing and Route of Epinephrine in a Neonatal Model of
Asphyxial Arrest
Payam Vali, MD; Praveen Chandrasekharan, MD; Munmun Rawat, MD; Sylvia Gugino, MA; Carmon Koenigsknecht, BS; Justin Helman, MS;
William J. Jusko, PhD; Bobby Mathew, MD; Sara Berkelhamer, MD; Jayasree Nair, MD; Myra H. Wyckoff, MD; Satyan Lakshminrusimha, MD
Background-—Epinephrine administered by low umbilical venous catheter (UVC) or endotracheal tube (ETT) is indicated in
neonates who fail to respond to positive pressure ventilation and chest compressions at birth. Pharmacokinetics of ETT
epinephrine via fluid-filled lungs or UVC epinephrine in the presence of fetal shunts is unknown. We hypothesized that epinephrine
administered by ETT or low UVC results in plasma epinephrine concentrations and rates of return of spontaneous circulation
(ROSC) similar to right atrial (RA) epinephrine.
Methods and Results-—Forty-four lambs were randomized into the following groups: RA epinephrine (0.03 mg/kg), low UVC
epinephrine (0.03 mg/kg), postcompression ETT epinephrine (0.1 mg/kg), and precompression ETT epinephrine (0.1 mg/kg).
Asystole was induced by umbilical cord occlusion. Resuscitation was initiated following 5 minutes of asystole. Thirty-eight of 44
lambs achieved ROSC (10/11, 9/11, and 12/22 in the RA, UVC, and ETT groups, respectively; subsequent RA epinephrine resulted
in a total ROSC of 19/22 in the ETT groups). Median time (interquartile range) to achieve ROSC was significantly longer in the ETT
group (including those that received RA epinephrine) compared to the intravenous group (4.5 [2.9–7.4] versus 2 [1.9–3] minutes;
P=0.02). RA and low UVC epinephrine administration achieved comparable peak plasma epinephrine concentrations (470250
versus 450190 ng/mL) by 1 minute compared to ETT values of 13060 ng/mL at 5 minutes; P=0.03. Following ROSC with ETT
epinephrine alone, there was a delayed peak epinephrine concentration (652240 ng/mL).
Conclusions-—The absorption of ETT epinephrine is low and delayed at birth. RA and low UVC epinephrine rapidly achieve high
plasma concentrations resulting in ROSC. ( J Am Heart Assoc. 2017;6:e004402. DOI: 10.1161/JAHA.116.004402.)
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B irth asphyxia accounts for about 23% of the 4 millionneonatal deaths that occur each year worldwide.1 The
majority of newborn infants require little assistance to
stabilize at birth and adapt seamlessly to extrauterine life.
However, 10% of infants require some assistance to begin
breathing at birth, although less than 1% need extensive
resuscitative measures such as chest compressions and
epinephrine.2,3 Beyond high rates of associated mortality,
newborns who fail to respond to optimized ventilation, and
who require chest compressions and pharmacologic therapy
to achieve return of spontaneous circulation (ROSC), are at
high risk of associated long-term neurologic deficits.4,5
The optimal route, order, and timing of epinephrine
administration remain controversial. Most recommendations
for epinephrine use are extrapolated from 1- to 4-day-old
animal models that have transitioned from the fetal circulation
(ie, they have decreased pulmonary vascular resistance, a
closed ductus arteriosus, and possible closed ductus venosus)
and have also cleared their lung fluid.6,7 The effect and
pharmacokinetics of epinephrine through an endotracheal
tube (ETT) into fluid-filled lungs, or into a low umbilical venous
catheter (UVC) in the presence of fetal shunts (ductus
venosus and foramen ovale), in perinatal asphyxia-induced
arrest are not known. In the clinical setting, administration of
intravenous (IV) epinephrine requires placement of an UVC,
so, in most instances, the first dose of epinephrine is given by
the ETT route.2,8
The current edition of the Neonatal Resuscitation Program
textbook recommends administering epinephrine at a dose of
0.01 to 0.03 mg/kg through a low UVC followed by a flush
of 0.5 to 1 mL of normal saline.9 While attempting placement
of a UVC, a dose of endotracheal epinephrine may be
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administered at a dose of 0.05 to 0.1 mg/kg.9 We elected to
determine the pharmacokinetics and safety profile of the
upper end of these dose ranges. We hypothesized that in the
setting of perinatal asphyxial arrest, high-dose ETT epinephr-
ine (0.1 mg/kg) delivery into fluid-filled lungs or epinephrine
administered into a low-lying UVC (0.03 mg/kg), in the
presence of a ductus venosus, will result in epinephrine
concentrations and ROSC rates similar to epinephrine
administered into the right atrium (0.03 mg/kg). We chose
the upper limit of the recommended dose for endotracheal
and umbilical venous epinephrine to optimize ROSC rates. We
also hypothesized that precompression ETT epinephrine
administration, prior to the initiation of chest compressions,
rapidly increases subsequent plasma epinephrine concentra-
tions and diastolic blood pressure, with the onset of chest
compressions achieving quicker ROSC. We speculated that
instilling epinephrine into the ETT prior to initiating positive
pressure ventilation (PPV) could distribute the drug within the
fluid-filled lungs more homogeneously during the 30 s of
ventilation, and then enhance/hasten the effects of epinephr-
ine once chest compressions are started.
Methods
Animal Preparation
This study was approved by the Institutional Animal Care and
Use Committee at the State University of New York at Buffalo.
Time-dated term (139–141-day gestation) pregnant ewes
were obtained from May Family Enterprises (Buffalo Mills, PA).
Following an overnight fast, the ewes were induced for
anesthesia with intravenous diazepam and ketamine. They
were intubated with a 10.0-mm cuffed ETT and ventilated with
21% oxygen and 2% to 3% isoflurane at 16 breaths/min. The
ewes were continuously monitored with a pulse oximeter and
an end-tidal CO2 monitor. Following cesarean section, fetal
lambs were partially exteriorized and intubated. The excess
fetal lung fluid in the ETT was drained passively by gravity by
tilting the head to the side to simulate loss of lung liquid with
labor and, thereafter, the ETT was occluded to prevent gas
exchange during gasping in the asphyxial period.10 Catheters
were inserted into the jugular vein (for fluid and medication
administration) and right carotid artery (for blood sampling). A
2-mm flow probe (Transonic Systems Inc, Ithaca, NY) was
placed around the left carotid artery. A left thoracotomy was
performed and a 4-mm flow probe was placed around the left
pulmonary artery. The thoracotomy was closed in layers. ECG
leads were attached at the right axilla, left axilla, and right
inguinal area (3-lead ECG). The ECG100C (Biopac Systems,
Inc.) was used with Acknowledge Software to record tracings
of leads I, II, and III. Preductal arterial oxyhemoglobin
saturation was monitored with a pulse oximeter placed on
the right forelimb of the lamb (Masimo, Irvine, CA). Following
instrumentation, the umbilical cord was occluded and cut, and
the lambs were moved from the maternal abdomen to the
radiant warmer. During the asphyxial period, an umbilical
arterial catheter was inserted in all lambs to measure
continuous invasive blood pressures. A low umbilical venous
catheter was inserted 2 cm below the skin (and secured after
confirming blood drawing back into the catheter) in lambs
randomized to receive UVC epinephrine (Figure 1).
Experimental Protocol
Forty-four lambs were randomized into 4 groups using opaque
sealed envelopes. A 5-minute period of asystole was observed
prior to initiating resuscitation. Asystole was defined by the
absence of carotid blood flow, arterial blood pressure, and
heart rate (by auscultation and ECG). Resuscitation began by
removing the ETT occluder and providing PPV with 21%
oxygen by means of a T-piece resuscitator at pressures of 35/
5 cm H2O at a rate of 40 breaths/min.
10 Pressures of 35/
5 cm H2O are required to deliver standard tidal volumes of
8 to 9 mL/kg in term lambs, which is necessary to achieve
normal PaCO2 concentrations.
11,12 Following 30 s of ventila-
tion, chest compressions at a compression-to-ventilation ratio
of 3:1 were commenced with a simultaneous increase in
inspired oxygen to 100%. Following intravenous epinephrine
administration, a flush of normal saline was given (0.5 mL/kg
to 2 mL for a 4-kg lamb). ETT epinephrine was administered
into the hub connecting the ETT and positive-pressure breaths
were provided to help distribute the drug in the lungs as is
currently recommended by the Neonatal Resuscitation Pro-
gram. The concentration of IV and ETT epinephrine used was
1:10 000 (0.1 mg/mL, eg, 0.1 mg/kg=1 mL/kg). The first
arterial blood sample or “arrest gas” was obtained 1 minute
prior to resuscitation (4 minutes into asystole). Thereafter,
blood sampling was obtained approximately every minute
during resuscitation. In lambs that achieved ROSC, a blood
gas sample was obtained at the time of ROSC and then every
1 to 3 minutes until 10 minutes following ROSC. Arterial
blood samples were analyzed using a radiometer blood gas
analyzer (ABL 800 FLEX, Denmark). Plasma epinephrine was
measured at baseline, prior to cord occlusion, and at arrest.
During resuscitation, epinephrine plasma concentrations were
drawn prior to injection of the drug and, thereafter, every
minute following epinephrine administration. Plasma epi-
nephrine concentrations were analyzed by ELISA (Eagle
Biosciences, Nashua, NY).
The lambs were randomized as follows:
Right atrial epinephrine: Epinephrine 0.03 mg/kg doses
were administered through a jugular venous catheter
advanced into the right atrium (RA) 30 s after the onset of
chest compressions. If no ROSC was achieved, repeat
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epinephrine doses were given every 3 minutes until ROSC or
for a total of 4 doses.
Low UVC epinephrine: Epinephrine 0.03 mg/kg was
administered into the umbilical vein through a low-lying
UVC. The first dose was administered 30 s following chest
compression initiation. Repeat epinephrine doses where given
every 3 minutes via a low-lying UVC.
Postcompression ETT: The first dose of epinephrine at
0.1 mg/kg was given 30 s after the onset of chest
compressions. If ROSC was not achieved, a second dose of
Figure 1. Schematic of study lamb illustrating invasive and noninvasive monitoring. ABG indicates arterial
blood gas; ETT, endotracheal tube; PPV, positive pressure ventilation; UVC, umbilical venous catheter.
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ETT epinephrine was given 3 minutes later. If the lambs failed
to respond to ETT epinephrine, intravenous epinephrine at
0.03 mg/kg through the RA was given every 3 minutes for 2
more doses as needed.
Precompression ETT: The first dose of 0.1 mg/kg ETT
epinephrine was administered with PPV prior to the onset of
chest compressions. Additional doses were administered as
described with postcompression ETT above.
Data Analysis
Arterial blood flow and pressures were continuously recorded
using a computer with AcqKnowledge Acquisition & Analysis
Software (BIOPAC systems, Goleta, CA). Continuous variables
are expressed as mean and SD. Categorical variables were
analyzed using v2 test with Fisher’s exact test as required.
Continuous variables were analyzed by 1-way ANOVA
between groups with Fisher’s post hoc test within groups.
Cox proportional hazards model was used to analyze time
variables. SPSS 24 (IBM, Armonk, NY) was used for statistical
analysis. Statistical significance was defined as P<0.05.
Results
Characteristics of the lambs, including baseline hemodynam-
ics, hemoglobin, sex distribution, birth weight, arterial blood
gases, and the amount of lung liquid drained by gravity were
not statistically significant among the study groups (Table 1).
Cord occlusion caused severe acidosis and bradycardia in all
lambs as we have previously described.11 Time to cardiac
arrest (asystole) was comparable in the groups. The time to
ROSC was significantly delayed in the ETT epinephrine groups
as compared to the intravenous groups (Table 1).
Incidence of ROSC and Tachyarrhythmias
RA epinephrine: Direct administration of epinephrine into the
RA through the jugular venous catheter resulted in ROSC in
Table 1. Baseline Characteristics, Hemodynamics, Arterial Blood Gas Analysis, and Timing and Incidence of ROSC in the 4 Study
Groups
Group 1
RA (n=11)
Group 2
UVC (n=11)
Group 3
Postcompression
ETT (n=11)
Group 4
Precompression
ETT (n=11)
Weight, kg 3.60.6 3.60.8 3.70.9 3.90.9
Sex (M:F) 7:4 5:6 6:5 5:6
Total lung fluid drained, mL/kg 133.5 152.6 156.7 183.8
Hemoglobin, g/dL 12.82.3 121.7 12.51.0 12.40.8
Baseline hemodynamics
Heart rate, bpm 15424 17429 15726 16025
SBP mean, mm Hg 568.5 5910 5312 4815
DBP mean, mm Hg 396.8 449.5 387.3 3211
Mean left carotid flow,
mL/kg per minute
267.1 328.5 258.7 278.8
Baseline ABG
pH 7.220.11 7.100.09 7.150.08 7.160.14
PaCO2, mm Hg 6415 677 6911 687
PaO2, mm Hg 242.8 195.2 2110 203.5
SpO2, % 647 5412 6120 578
Lactate, mmol/L 3.91.4 4.93.6 6.13.2 4.83.5
Time to asystole, minute 18 (16–21) 14 (12–20) 15 (14–16) 14 (12–14)
ROSC 10/11 (91%) 9/11 (82%) 8/11 (73%)
After RA epi (9/11)
4/11 (36%)
After RA epi (10/11)
Time to ROSC, minute 2 (1.6–2.9) 2.5 (2–3) 4 (2.9–4.8)* 7 (3–8)†
Data are meanSD; time variables are median (interquartile ranges). ABG indicates arterial blood gas; bpm, beats per minute; DBP, diastolic blood pressure; epi, epinephrine; ETT,
endotracheal tube; RA, right atrium; ROSC, return of spontaneous circulation; SBP, systolic blood pressure; SpO2, preductal arterial oxyhemoglobin saturation; UVC, umbilical venous
catheter.
*P<0.05 compared to group 1.
†P<0.05 compared to group 1 and group 2.
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10/11 lambs. Nine lambs were resuscitated with 1 dose of
epinephrine and 1 lamb required 2 doses.
UVC epinephrine: Administration of epinephrine through
the low UVC resulted in ROSC in 9/11 lambs. Eight lambs
received 1 dose of epinephrine and 1 lamb required 4 doses
of epinephrine to achieve ROSC. One lamb developed a
supraventricular tachyarrhythmia a few minutes following
ROSC and could not be converted to normal rhythm despite
vagal stimulation and repeated doses of adenosine (ROSC
was not sustained).
Postcompression ETT epinephrine: The first postcompres-
sion dose of ETT epinephrine led to ROSC in 4/11 lambs. Four
more lambs achieved ROSC following the second dose of ETT
epinephrine. One lamb required 1 dose of RA epinephrine
following the 2 doses of ETT epinephrine to be successfully
resuscitated. Of the other 2 lambs that received IV
epinephrine that did not achieve ROSC, 1 developed a
tachyarrhythmia 2 minutes following ROSC and could not
be converted into sinus rhythm despite medical treatment
(ROSC was not sustained).
Precompression ETT epinephrine: Precompression ETT
administration of epinephrine led to ROSC in 4/11 lambs.
Three lambs achieved ROSC with the first precompression
ETT dose of epinephrine, 1 lamb achieved ROSC following 2
doses of ETT epinephrine, and 6 of the remaining 7 lambs
achieved ROSC following intravenous epinephrine. One lamb
that received 2 doses of ETT followed by intravenous
epinephrine developed a ventricular tachycardia during
resuscitation, which was initially treated with calcium
gluconate without success. A rhythm strip appeared to
show torsade de pointes (Figure 2) and magnesium sulfate
and lidocaine were administered in an attempt to convert to
normal sinus rhythm. The lamb converted to sinus rhythm
and achieved ROSC at 42 minutes and sustained normal
hemodynamic parameters until sacrifice. As an extreme,
atypical clinical course, this lamb was counted as a
successful ROSC but the time to ROSC was omitted from
the average mean.
The incidence of ROSC by group is shown in Figure 3.
Hemodynamic Parameters
There were no significant differences at any time in the
systolic and diastolic blood pressures, left carotid and left
pulmonary blood flows, and the heart rate among the groups
(Figures 4 and 5). At the onset of chest compressions, the
systolic blood pressures ranged from 25 to 28 mm Hg, which
increased to 29 to 33 mm Hg following epinephrine. The
diastolic blood pressures followed a similar pattern with
pressures of 6 to 8 mm Hg at the beginning of chest
compressions that increased to 9 to 13 mm Hg following
epinephrine.
Following ROSC, there was a significant increase in systolic
and diastolic blood pressures (Figure 4A and 4B). However,
blood pressures started normalizing by the end of the study
period (69–83/52–60 mm Hg), similar to historical nonas-
phyxiated control term lambs during the first 10 minutes of
postnatal age (65–108/50–62 mm Hg). The chest compres-
sion rate was maintained between 85 and 90 compressions
per minute during resuscitation. The heart rates quickly
increased upon ROSC and tachycardia persisted for the
duration of the study (Figure 4C). When analyzing the lambs
that achieved ROSC following only ETT epinephrine (n=12),
blood pressures and heart rate after ROSC also rose to similar
values compared to the intravenous groups.
The maximum carotid and pulmonary blood flows
increased following epinephrine administration but did not
achieve statistical significance as compared to the period
prior to epinephrine administration (Figure 5A and 5B). An
interesting observation during resuscitation was the negative
minimum carotid and pulmonary blood flow values, where
reversal of flow occurred during the relaxation (“diastolic”)
Figure 2. Tachyarrhythmia (torsades de pointes) in a lamb that
received multiple epinephrine doses.
Figure 3. Animals achieving ROSC with varied epinephrine
route by group. In the UVC group, the checkered bar represents
4 UVC epinephrine doses. The purple bars represent the lambs
that received 2 ETT epinephrine doses followed by 1 dose of RA
epinephrine prior to achieving ROSC. CC indicates chest
compression; EPI, epinephrine; ETT, endotracheal tube; RA, right
atrium; ROSC, return of spontaneous circulation; UVC, umbilical
venous catheter.
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phase of chest compressions (Figure 5B and 5D). Following
ROSC, these values became positive, demonstrating forward
flow in the carotid and pulmonary arteries during the systolic
as well as diastolic phases of the cardiac cycle (Figure 6).
Plasma Epinephrine Concentrations
Baseline and arrest plasma epinephrine concentrations were
similar, ranging from 3 to 20 ng/mL. Results from lambs that
received only 1 dose of epinephrine (ETT, UVC, or RA) are
shown in Figure 7. Intravenous injection of epinephrine
(0.03 mg/kg) through the jugular catheter into the right
atrium or into the umbilical vein through a low-lying UVC
resulted in similar peak plasma concentrations (470250
versus 450190 ng/mL) within 1 minute of epinephrine
administration. Instillation of ETT epinephrine (0.1 mg/kg)
resulted in significantly lower (13060 ng/mL) and delayed
(4–5 minutes following epinephrine administration) peak
concentrations; P<0.05.
Results from the lambs that received multiple doses of
epinephrine are presented in Figure 8. When analyzing the
data of the lambs randomized to the ETT epinephrine groups
that also received IV epinephrine, there was a slow rise in the
plasma epinephrine concentrations following the ETT epi-
nephrine doses (peak of 350 ng/mL at 6 minutes), whereas
a sharp rise in plasma concentration was observed following
the intravenous dose (peak of 800 ng/mL). In the lambs
that exclusively received intravenous epinephrine, there was a
steady cumulative rise in plasma concentration after each
epinephrine injection to peak values exceeding 1000 ng/mL
in the animals that received a total of 4 doses. Interestingly,
there was also a continued increase in the plasma epinephrine
concentrations following ROSC in the lambs that received only
ETT epinephrine (Figure 9). Multiple epinephrine doses were
Figure 4. Systolic (A) and diastolic (B) blood pressures, and heart rate (C) are similar among groups. Epinephrine did not significantly increase
systolic (A) or diastolic (B) pressures during chest compressions. The chest compression rate was maintained around 90 per minute (C). In the
lambs that achieved ROSC, there was a significant increase in systolic (A) and diastolic (B) blood pressures that started to improve by the end of
the study. Heart rate stayed high following ROSC (C). Data are meanSEM. CC indicates chest compression; EPI, epinephrine; ETT, endotracheal
tube; RA, right atrium; ROSC, return of spontaneous circulation; UVC, umbilical venous catheter.
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associated with tachyarrhythmias in 3 lambs (1/11 lambs in
the UVC group, and 2/22 in the ETT groups following an IV
dose).
Arterial Blood Gas Analysis
There were no significant differences in the PaO2, PaCO2,
lactate, and pH among the groups throughout the resuscita-
tion period (adequate ventilation was achieved by monitoring
tidal volumes). In the lambs that were successfully resusci-
tated (excluding the lamb with an arrhythmia that achieved
ROSC after a prolonged resuscitation; n=37), the arterial
blood gas samples collected at the time of arrest, 1 minute
preceding ROSC, at ROSC, 1 minute following ROSC, and
10 minutes following ROSC are shown in Table 2. The
hemoglobin concentration remained constant with an average
hemoglobin concentration of 12.11.4 g/dL by the end of
the study. Thus, the lambs achieved ROSC with a mean
arterial oxygen tension of 25 mm Hg (fetal hemoglobin
saturation of 65%) equivalent to an oxygen content of
10.7 mL/dL. With low mean carotid blood flows during chest
compressions, mean oxygen delivery from the left carotid
artery was only 4.31.2 mL O2/kg per minute (compared to
256.3 mL O2/kg per minute during fetal baseline and
409.1 mL O2/kg per minute 10 minutes after ROSC). Also,
very high PaO2 values (>200 mm Hg) were seen within the
first few minutes following ROSC despite gradually weaning
the FIO2 once ROSC was confirmed. The PaO2 normalized
within the first 10 minutes when all lambs had been weaned
to an FIO2 of 0.21 (Table 2).
Discussion
Epinephrine has been used in cardiopulmonary resuscitation
since the early 1960s.12 However, because of the infrequent
Figure 5. Maximum (A) andminimum (B) left carotid blood flows, andmaximum (C) andminimum (D) left pulmonary blood flows are similar among
groups. Epinephrine did not significantly increase blood flows during chest compression. Minimum left carotid (B) and minimum left pulmonary (D)
bloodflowsare retrograde during the relaxation (“diastolic”) phase of chest compressions.Minimumpulmonary bloodflows (D) are also retrograde in
the fetus at baseline because of the high pulmonary vascular resistance in utero. Data are meanSEM. CC indicates chest compression; ETT,
endotracheal tube; RA, right atrium; ROSC, return of spontaneous circulation; UVC, umbilical venous catheter.
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use of medications during neonatal resuscitation, there is a
lack of rigorous scientific evidence for the effects of
epinephrine use in the neonatal population. Therefore, the
appropriate dosing, timing, order, and route of epinephrine
administration remain controversial.3 This study is the first
attempt to evaluate the efficacy, pharmacokinetics, and safety
profile of ETT and low UVC epinephrine in a newborn asphyxial
arrest model. This model includes 5 minutes of asystole
following cord occlusion resembling severe asphyxia with
cardiac arrest, which typically requires PPV, chest compres-
sions, and epinephrine to achieve ROSC.
The use of high-dose IV epinephrine (0.2 mg/kg) in a
pediatric swine cardiac arrest model has been associated with
severe tachycardia, hypertension, and higher mortality in the
A
B
C
Figure 6. Snapshot of Biopac showing umbilical arterial pressure (A), left carotid blood flow (B), and left pulmonary arterial blood flow (C) from
asystole through resuscitation and ROSC. Dashed line represents value “0.” Blood flows below dashed lines represent retrograde flow. With
ROSC and cessation of chest compressions, blood flow is exclusively anterograde. CC indicates chest compressions; ETT, endotracheal tube;
PA, pulmonary artery; RA, right atrium; ROSC, return of spontaneous circulation; UA, umbilical artery.
Figure 7. Plasma epinephrine concentrations from lambs that received 1 dose of epinephrine. The
precompression ETT and postcompression ETT groups were combined in this graph. Arrow indicates time of
epinephrine administration. Data are meanSEM. ETT indicates endotracheal tube; RA, right atrium; UVC,
umbilical venous catheter.
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immediate postresuscitation period.13 In neonatal lambs, the
use of high-dose IV epinephrine (0.1 mg/kg) results in
reduced stroke volume and cardiac output.14 In addition,
there is no evidence of improved clinical outcomes to support
the use of high-dose intravenous epinephrine in adults.15,16
The findings from the current study establish the efficacy of
epinephrine administered into the RA at a dose of 0.03 mg/
kg followed by a 0.5 mL/kg normal saline flush. Optimal
plasma concentrations similar to that described in other
animal models were achieved with a high incidence of ROSC
(10/11 lambs) at 2.41.1 minutes after the onset of
resuscitation (or 8465 s after intravenous epinephrine
administration).6 Seven additional lambs in the ETT groups
achieved ROSC following IV RA epinephrine. Time to ROSC
Figure 8. Plasma epinephrine concentrations from lambs that received multiple doses of epinephrine. All
lambs in the ETT followed by IV group required at least 1 dose of intravenous epinephrine. Arrows indicate
epinephrine administration. In the IV followed by IV group, all doses were IV at 0.03 mg/kg. In the ETT
followed by IV group, epinephrine for the first 2 doses was 0.1 mg/kg by ETT, followed by IV epi at
0.03 mg/kg. Data are meanSEM. ETT indicates endotracheal tube.
Figure 9. Plasma epinephrine concentrations in lambs that achieved ROSC following 2 doses of tracheal
epinephrine without any intravenous epinephrine. The peak value at 8 minutes (ie, 4 minutes after the last
ETT dose) occurred following ROSC. Arrows indicate ETT epinephrine at 0.1 mg/kg. Data are meanSEM.
ETT indicates endotracheal tube; ROSC, return of spontaneous circulation.
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following the RA epinephrine dose in those 7 lambs was
8233 s.
Administration of epinephrine at the same dose (0.03 mg/
kg followed by 0.5 mL/kg of flush) into the umbilical vein
through a low-lying UVC resulted in similar peak plasma
concentrations and similar rates of ROSC (9/11 lambs). Time
to ROSC was prolonged as compared to RA epinephrine
(3.12.7 minutes after onset of resuscitation or 126122 s
after epinephrine administration) although this difference was
not statistically significant.
The high frequency of initial use of ET epinephrine clinically
(while attempting to establish UVC access) makes it critical
that the recommended dose be as effective as possible.
Studies in newborn piglets (2–4 days old) observed no
increase in plasma epinephrine concentrations after the
recommended IV epinephrine dose (0.01 mg/kg) is
administered via ETT.6 Another piglet study has shown that
higher-dose ETT epinephrine (0.07 mg/kg) is associated with
an 89% success rate in achieving ROSC.17 Therefore, when
administering endotracheal epinephrine, a higher dose is
likely required to compensate for the lung liquid dilution as
well as to overcome the diffusion barrier at the level of the
alveolar capillaries. In our study, we elected to administer the
higher range of endotracheal epinephrine at a dose of
0.1 mg/kg as currently recommended by the Neonatal
Resuscitation Program.18 Out of the 22 lambs that received
ETT epinephrine, only 7 (32%) achieved ROSC following the
first dose of epinephrine. Another 5 lambs were successfully
resuscitated following a second dose of ETT epinephrine (total
ETT epinephrine ROSC success of 12/22=55%). However, the
epinephrine concentrations achieved were significantly lower
and peak concentrations were markedly delayed compared to
Table 2. Arterial Blood Gas Analysis in the 4 Study Groups
Group 1
RA
Group 2
UVC
Group 3
Postcompression
ETT
Group 4
Precompression
ETT
At arrest N=11 N=11 N=11 N=11
pH 6.850.07 6.800.09 6.850.06 6.850.04
PaCO2, mm Hg 13027 14625 13917 13217
PaO2, mm Hg 5.53.5 6.04.5 6.04.5 5.83.5
Lactate, mmol/L 12.15.4 14.66.7 13.94.9 14.85.1
1 minute before ROSC N=10 N=9 N=9 N=9
pH 6.880.15 6.800.16 6.850.06 6.830.07
PaCO2, mm Hg 11727 12445 10615 11827
PaO2, mm Hg 249.1 256.9 256.6 246.2
Lactate, mmol/L 13.63.5 13.55.9 15.34.5 164.8
At ROSC N=10 N=9 N=9 N=9
pH 6.820.06 6.790.16 6.860.06 6.810.07
PaCO2, mm Hg 11629 11547 9714 11539
PaO2, mm Hg 119127 161209 90106 157173
Lactate, mmol/L 14.42.4 14.55.1 14.84.5 16.54.9
1 minute after ROSC N=10 N=9 N=9 N=9
pH 6.850.09 6.790.11 6.900.10 6.910.11
PaCO2, mm Hg 10041 10529 9425 10122
PaO2, mm Hg 261148 221204 208136 224173
Lactate, mmol/L 13.51.4 15.43.1 14.74.1 15.55.3
10 minute after ROSC (FIO2 0.21) N=10 N=9 N=9 N=9
pH 7.070.15 7.000.99 7.090.13 7.010.12
PaCO2, mm Hg 5628 6619 5019 5414
PaO2, mm Hg 8134 6311 7117 7428
Lactate, mmol/L 14.45.5 14.35.4 12.43.8 15.35.7
N represents the number of lambs. Data are meanSD. ETT indicates endotracheal tube; RA, right atrium; ROSC, return of spontaneous circulation; UVC, umbilical venous catheter.
DOI: 10.1161/JAHA.116.004402 Journal of the American Heart Association 10
Evaluation of Timing and Route of Epinephrine Vali et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
RA or UVC administration of epinephrine (Figure 7). Another
concern with endotracheal administration was the high
plasma epinephrine concentrations achieved after establish-
ment of ROSC (Figure 8). We speculate that improved
pulmonary blood flow and slow absorption of epinephrine
from the fluid-filled lungs resulted in higher plasma concen-
trations. Though we did not observe any hemodynamic
compromise in the immediate recovery phase (lambs were
monitored for 30 minutes from onset of resuscitation),
previous studies have shown that ETT epinephrine can worsen
the hemodynamics by reducing systemic vascular resistance
due to greater b- versus a-adrenergic effects.19,20 Therefore,
the depot effect and the delayed absorption following ETT
epinephrine, especially if IV epinephrine has also been
administered, may potentiate increased adverse effects after
ROSC because of the high plasma epinephrine concentra-
tions. Following IV epinephrine, a total of 19/22 lambs in the
endotracheal groups achieved ROSC, which is comparable to
the IV groups. Further studies evaluating the safety profile of
multiple ETT epinephrine doses (at 0.1 mg/kg) are necessary.
Contrary to our hypothesis, precompression administration of
ETT epinephrine was not effective in restoring ROSC (4/11
lambs). Our assumption that instilling epinephrine into the ETT
while providing PPV to distribute the medicine more homo-
geneously into the fluid-filled lungs prior to starting chest
compressions to enhance/hasten the effects of epinephrine
was incorrect. In the absence of chest compressions and
pulmonary blood flow, epinephrine absorption from the lungs
is not adequate.
Three lambs developed tachyarrhythmias: 1 following
administration of multiple UVC epinephrine doses during
resuscitation and could not be converted, another 2
minutes after ROSC was achieved following RA epinephrine
plus 2 earlier doses of ETT epinephrine (also could not be
converted), and, finally, 1 developed arrhythmias during
resuscitation and ultimately converted to sinus rhythm
following administration of calcium gluconate, magnesium
sulfate, and lidocaine. Tachyarrhythmias have been previously
reported in a piglet newborn model comparing the efficacy of
vasopressin with epinephrine.21 Neonatal healthcare provi-
ders should be aware that severely compromised neonates
are at risk for development of arrhythmias if multiple doses of
epinephrine are administered. The 2015 Neonatal Resuscita-
tion Program guidelines recommendation for ECG monitoring
in the delivery room may lead to increased identification of
arrhythmias.22
Hemodynamic effects of epinephrine administration in a
newborn model with patent fetal shunts (ductus arteriosus,
patent foramen ovale, and ductus venosus) have been better
characterized by our study. In this neonatal asphyxial cardiac
arrest model with transitioning fetal circulation, we observed
significant retrograde pulmonary and carotid blood flow during
the relaxation (“diastolic”) phase of chest compressions, the
latter corroborating findings by Sobotka et al.10 Furthermore,
contrary to studies in adult and pediatric models, epinephrine
did not significantly elevate blood pressure or coronary
perfusion pressure.10,23–26 Coronary perfusion pressure acts
as a surrogate for myocardial blood flow and in the
intrinsically beating heart, myocardial blood flow is at its
greatest during diastole when the heart muscles relax.
However, in the arrested neonatal heart with fetal shunts, it
is not known whether myocardial blood flow is greatest during
compression (systole) or relaxation (diastole). Our data
suggest that systolic blood pressures may be more predictive
of ROSC as the lambs in this study achieved ROSC with low
mean diastolic blood pressures (10 mm Hg).
We speculate that the rapid achievement of ROSC was
associated with the higher and more rapid plasma epinephrine
concentration achieved with intravenous epinephrine, medi-
ated by epinephrine’s b-adrenergic effects on the myocytes,
as well as on the sinoatrial and atrioventricular nodes, leading
to improved impulse generation, conduction velocity, and
contractility during chest compressions.27 The diminished
response in elevating the blood pressures suggests that the a-
adrenergic effects of epinephrine in this severely asphyxiated
acidotic model may be blunted during resuscitation.
Finally, the significant rise in PaO2 following ROSC when
ventilating in 100% oxygen raises concern of the potential
deleterious effects of excess oxidative stress and risk of free
radical generation with risk of potentiating long-term neuro-
logic deficits.11,28–30 We therefore suggest decreasing the FIO2
to 0.21 immediately following ROSC and, thereafter, adjust the
FIO2 accordingly to maintain saturations in the goal ranges.
31
We acknowledge several limitations to this study. A flow
probe was not placed around the ductus arteriosus, limiting
our interpretation and understanding of the hemodynamics of
chest compression during resuscitation in a model with
transitioning circulation. Instrumentation of the fetal lambs
was performed just prior to our study and may have induced
stress. In addition, although we sutured the thoracotomy in
layers, we may have altered mechanical properties of the
thoracic cage during chest compressions. Finally, we cannot
be certain that some lambs may achieve ROSC if the time to
first epinephrine administration is extended.
Conclusions
This is the first reported study in the literature investigating
the effects and pharmacokinetics of epinephrine administra-
tion at different sites (RA, low UVC, and ETT route) in a
neonatal asphyxial cardiac arrest model with transitioning
fetal circulation and fluid-filled lungs. RA and low UVC
epinephrine administration achieve significantly higher and
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quicker peak plasma epinephrine concentrations with a high
ROSC success rate (81–91%), whereas the systemic absorp-
tion of ETT epinephrine through liquid-filled lungs is low and
delayed. Future studies evaluating a single higher dose of
epinephrine (0.2 mg/kg) are warranted.
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